Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer
Condition: Breast Cancer Stage III Interventions: Radiation: Whole breast / chest wall& regional lymph node irradiation; Radiation: Internal mammary or supraclavicular lymph node boost Sponsor: Samsung Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2023 Category: Research Source Type: clinical trials
NIH ’s ComboMATCH Initiative Will Test New Drug Combinations Guided by Tumor Biology
June 1, 2023 -- The National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to test the effectiveness of treating adults and children with new drug combinations that target specific tumor alterations.... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 1, 2023 Category: Pharmaceuticals Source Type: clinical trials
Rollover Study From EXG-US-01
Condition: Telomere Biology Disorders With Bone Marrow Failure Intervention: Biological: EXG34217 Sponsor: Elixirgen Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials
